Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -3.22%1.32B | -2.85%6.32B | -7.00%1.63B | 2.18%1.86B | 0.24%1.46B | -7.21%1.37B | -8.30%6.5B | -8.10%1.75B | -12.57%1.82B | -3.12%1.46B |
Operating revenue | -3.22%1.32B | -2.85%6.32B | -7.00%1.63B | 2.18%1.86B | 0.24%1.46B | -7.21%1.37B | -8.30%6.5B | -8.10%1.75B | -12.57%1.82B | -3.12%1.46B |
Cost of revenue | 0.01%1.16B | -3.16%5.38B | -6.13%1.38B | 3.25%1.59B | -1.73%1.25B | -8.87%1.16B | -3.50%5.56B | -6.31%1.47B | -7.42%1.54B | 1.22%1.27B |
Gross profit | -21.85%157.58M | -1.05%933.21M | -11.61%246.71M | -3.63%272.48M | 13.65%212.38M | 3.71%201.64M | -29.09%943.15M | -16.50%279.11M | -32.87%282.75M | -25.00%186.87M |
Operating expense | -1.91%126.06M | 4.63%494.76M | -6.78%112.28M | 5.99%123.12M | 18.36%130.85M | 2.23%128.52M | 9.26%472.87M | 10.31%120.45M | 13.94%116.16M | 3.95%110.55M |
Selling and administrative expenses | -11.00%80.41M | 12.33%331.81M | -11.94%69.43M | 10.59%80.75M | 40.73%91.28M | 14.84%90.35M | 4.24%295.39M | 13.28%78.84M | 7.47%73.02M | -5.82%64.86M |
Research and development costs | 19.60%45.65M | -8.18%162.95M | 2.99%42.85M | -1.79%42.36M | -13.40%39.57M | -18.87%38.17M | 18.77%177.47M | 5.07%41.6M | 26.89%43.14M | 21.91%45.69M |
Operating profit | -56.89%31.52M | -6.77%438.46M | -15.27%134.44M | -10.34%149.37M | 6.82%81.53M | 6.44%73.13M | -47.58%470.29M | -29.51%158.66M | -47.82%166.6M | -46.56%76.32M |
Net non-operating interest income expense | -759.94%-2.36M | 105.65%596K | -17.71%-1.89M | 127.78%240K | 181.07%1.89M | 106.23%357K | 76.98%-10.54M | 81.63%-1.61M | 92.03%-864K | 81.54%-2.34M |
Non-operating interest income | -13.95%14.45M | 35.25%65.54M | 9.49%15.19M | 30.69%15.86M | 47.25%17.7M | 60.99%16.8M | 279.71%48.46M | 124.27%13.87M | 200.87%12.14M | 519.22%12.02M |
Non-operating interest expense | 2.25%16.81M | 10.08%64.95M | 10.34%17.08M | 20.16%15.62M | 10.11%15.81M | 1.68%16.44M | 0.75%59M | 3.58%15.48M | -12.62%13M | -1.64%14.35M |
Other net income (expense) | -125.05%-3.38M | 49.48%-8.04M | 155.15%3.05M | -130.12%-7.73M | -1,260.29%-1.85M | 78.19%-1.5M | -386.71%-15.9M | 17.56%-5.53M | -302.65%-3.36M | -102.23%-136K |
Gain on sale of security | -143.37%-3.76M | 51.77%-8.86M | 143.97%2.59M | -41.01%-7.98M | -3,820.41%-1.92M | 77.16%-1.55M | -1,268.00%-18.36M | 41.08%-5.89M | -658.64%-5.66M | -100.78%-49K |
Special income (charges) | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non- operating income (expenses) | 768.18%382K | -66.59%821K | 26.17%458K | -89.21%248K | 181.61%71K | 137.29%44K | -44.65%2.46M | -88.97%363K | 256.43%2.3M | -140.85%-87K |
Income before tax | -64.17%25.79M | -2.89%431.02M | -10.52%135.59M | -12.62%141.88M | 10.45%81.57M | 28.34%71.98M | -48.21%443.84M | -27.71%151.53M | -47.64%162.37M | -45.80%73.85M |
Income tax | -67.73%3.94M | -7.62%75.48M | -8.39%29.79M | -33.67%19.19M | 52.14%14.31M | 12.26%12.2M | -9.10%81.71M | -28.90%32.52M | 693.93%28.92M | -12.80%9.41M |
Net income | -63.45%21.85M | -1.82%355.54M | -11.10%105.8M | -8.06%122.69M | 4.37%67.26M | 32.20%59.79M | -52.79%362.13M | -27.38%119.01M | -56.45%133.45M | -48.64%64.44M |
Net income continuous Operations | -63.45%21.85M | -1.82%355.54M | -11.10%105.8M | -8.06%122.69M | 4.37%67.26M | 32.20%59.79M | -52.79%362.13M | -27.38%119.01M | -56.45%133.45M | -48.64%64.44M |
Minority interest income | -18.45%725K | -34.30%1.52M | -89.52%152K | -85.54%121K | 128.48%361K | 800.00%889K | 90.16%2.32M | 451.09%1.45M | 122.61%837K | -77.13%158K |
Net income attributable to the parent company | -64.13%21.13M | -1.61%354.01M | -10.13%105.65M | -7.57%122.57M | 4.06%66.9M | 29.87%58.9M | -53.02%359.81M | -28.45%117.56M | -56.67%132.61M | -48.48%64.29M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -64.13%21.13M | -1.61%354.01M | -10.13%105.65M | -7.57%122.57M | 4.06%66.9M | 29.87%58.9M | -53.02%359.81M | -28.45%117.56M | -56.67%132.61M | -48.48%64.29M |
Basic earnings per share | -62.50%0.09 | -1.37%1.44 | -10.42%0.43 | -7.41%0.5 | 3.85%0.27 | 33.33%0.24 | -53.35%1.46 | -28.36%0.48 | -56.80%0.54 | -49.02%0.26 |
Diluted earnings per share | -62.50%0.09 | -2.05%1.43 | -10.42%0.43 | -9.26%0.49 | 3.85%0.27 | 33.33%0.24 | -53.05%1.46 | -28.36%0.48 | -56.45%0.54 | -49.02%0.26 |
Dividend per share | 5.00%0.0827 | 5.00%0.3189 | 5.00%0.0827 | 5.00%0.0788 | 5.00%0.0788 | 5.00%0.0788 | 35.00%0.3038 | 5.00%0.0788 | 50.00%0.075 | 50.00%0.075 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |